The ScholarGPS website collects information through the use of "cookies" or similar technologies in order to function more efficiently and analyze use of the website. You are free to restrict or block cookies as further explained in our Cookies Policy, however depending on the selection of your settings, the full features/functionality of the website may no longer be available.
Decline
Share:
Amicus Therapeutics, Inc.
Philadelphia, Pennsylvania, United States
Amicus Therapeutics is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
